The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4207822
Max Phase: Preclinical
Molecular Formula: C21H15N3O2S
Molecular Weight: 373.44
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: O=C1CS/C(=N/N=C\c2cccc3ccccc23)N1C(=O)c1ccccc1
Standard InChI: InChI=1S/C21H15N3O2S/c25-19-14-27-21(24(19)20(26)16-8-2-1-3-9-16)23-22-13-17-11-6-10-15-7-4-5-12-18(15)17/h1-13H,14H2/b22-13-,23-21+
Standard InChI Key: OGXSDEAYEIHESH-HAVYBMPNSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 373.44Molecular Weight (Monoisotopic): 373.0885AlogP: 3.95#Rotatable Bonds: 3Polar Surface Area: 62.10Molecular Species: NEUTRALHBA: 5HBD: 0#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: 13.24CX Basic pKa: CX LogP: 4.31CX LogD: 4.31Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.40Np Likeness Score: -1.16
References 1. Carradori S, Bizzarri B, D'Ascenzio M, De Monte C, Grande R, Rivanera D, Zicari A, Mari E, Sabatino M, Patsilinakos A, Ragno R, Secci D.. (2017) Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity., 140 [PMID:28963991 ] [10.1016/j.ejmech.2017.09.026 ]